<DOC>
	<DOC>NCT00929201</DOC>
	<brief_summary>This study will demonstrate the bioequivalence of metformin after single dose administration of sitagliptin/metformin 50/500 mg fixed dose combination (FDC) tablet and concomitant administration of single doses of sitagliptin 50 mg and metformin 500 mg as individual tablets after consumption of a high-fat meal.</brief_summary>
	<brief_title>Sitagliptin/Metformin Fed Bioequivalence Study (0431A-080)</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>is in good health is a nonsmoker is willing to follow all study guidelines has or has a history of any illness or condition that might confound the results of the study or make participation unsafe for the participant is a nursing mother is unwilling to consume the required highfat breakfast</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>